Paroxetine (Paxil) Dosing Recommendations
For adults with depression, start paroxetine at 20 mg once daily in the morning, which is both the starting and optimal dose for most patients; for elderly patients (≥60 years), start at 12.5 mg daily with a maximum of 50 mg daily; for adolescents with depression, start at 10 mg daily with an effective dose of 20 mg and maximum of 60 mg daily, though paroxetine is not recommended to be initiated in primary care for this population. 1, 2
Adult Dosing (Ages 18-65)
Major Depressive Disorder
- Starting dose: 20 mg once daily (morning, with or without food) 1, 3
- Optimal dose: 20 mg/day for most patients 3, 4
- Dose escalation: If inadequate response after 1-3 weeks, increase in 10 mg increments at weekly intervals 3
- Maximum dose: 50 mg/day 1, 3
The 20 mg starting dose represents both the minimal effective dose and the optimal therapeutic dose for the majority of patients 3, 4. This is a key clinical point—most patients will not require dose escalation.
Social Anxiety Disorder
- Starting dose: 12.5 mg/day (Paxil CR formulation) 1
- Effective range: 20-50 mg/day for most patients 5
- Dose escalation: Increase at weekly intervals in 12.5 mg increments 1
- Maximum dose: 37.5 mg/day (CR formulation) or 60 mg/day (immediate release) 1
Panic Disorder
- Dosing range: 12.5-75 mg/day 1
- Follow similar escalation principles as depression
Elderly Patients (≥60 Years)
Start lower and go slower in this population due to altered pharmacokinetics and increased sensitivity to adverse effects 1, 6:
A 2009 randomized controlled trial specifically in late-life depression demonstrated that paroxetine CR 25 mg daily achieved significantly higher remission rates (41%) compared to 12.5 mg (31%) and placebo (28%), with both doses being well-tolerated 6. The 25 mg dose showed larger effect sizes and is the preferred target dose in elderly patients who tolerate initial therapy.
Critical consideration: Elderly patients show higher plasma concentrations and slower elimination, requiring dose adjustments 7, 8. They are also more susceptible to falls, hyponatremia, and cognitive effects.
Adolescent Dosing (Ages 12-17)
Based on the GLAD-PC guidelines 2:
- Starting dose: 10 mg once daily
- Dose escalation: Increase in 10 mg increments
- Effective dose: 20 mg/day
- Maximum dose: 60 mg/day
- Important caveat: Paroxetine is not recommended to be started in primary care for adolescents 2
Only fluoxetine is FDA-approved for depression in children and adolescents; only escitalopram is approved for adolescents ≥12 years 2. If paroxetine is used in adolescents, it should be initiated by specialists, not in primary care settings.
Black Box Warning for Adolescents
Close monitoring is mandatory, especially during the first few months and after dose changes, due to increased suicidality risk 2. Starting at higher doses increases the risk of deliberate self-harm 2.
Special Populations
Severe Renal or Hepatic Impairment
- Starting dose: 12.5 mg/day 1
- Maximum dose: 50 mg/day 1
- Elimination is significantly reduced in these patients 8
Pregnant Women (Third Trimester)
Consider tapering paroxetine in the third trimester due to neonatal complications (prolonged hospitalization, respiratory support, tube feeding) 1. Carefully weigh risks versus benefits.
Key Clinical Considerations
Administration
- Single daily dose, typically in the morning 1, 3
- Can be taken with or without food 1
- Paxil CR must be swallowed whole—do not chew or crush 1
Dose-Response Relationship
Recent therapeutic drug monitoring data suggests that plasma concentrations of 65-120 ng/mL at 4 weeks predict optimal clinical response at 8 weeks 9. Concentrations above 120 ng/mL increase adverse effects (liver injury, weight gain) without additional benefit 9.
Discontinuation
Always taper gradually rather than abrupt cessation to avoid withdrawal symptoms 1. If intolerable symptoms occur during taper, resume the previous dose and decrease more slowly 1.
Drug Interactions
- Contraindicated with MAOIs: Allow 14 days between stopping MAOI and starting paroxetine, and vice versa 2, 1
- CYP2D6 interactions: Paroxetine is both a substrate and potent inhibitor of CYP2D6 8, 10
- Critical interaction: Reduces tamoxifen efficacy—avoid in breast cancer patients on tamoxifen 10
- Serotonin syndrome risk: With linezolid, methylene blue, or other serotonergics 1
Common Adverse Effects
Most common dose-dependent effects include nausea, somnolence, sexual dysfunction, sweating, and tremor 11, 1. Paroxetine has higher rates of sexual dysfunction than other SSRIs and more weight gain than sertraline or venlafaxine 11. These effects are typically dose-dependent, supporting the use of the lowest effective dose 10.